Illumine Investment Management, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 2052970 POULSBO, WA

Back to NBIX Full portfolio

Position in NBIX

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$1,268,919

-$100,591 QoQ

Shares Held

9,632

-0.2% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

1.22%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Illumine Investment Management, LLC holds $6,405,667 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (19.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	7,735	$4,586,700
2	NBIX	Neurocrine Biosciences Inc This page	9,632	$1,268,919
3	AMPH	Amphastar Pharmaceuticals, Inc.	28,078	$550,048

All Filings in NBIX

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,268,919	9,632	-0.2%	Shares	Sole	2026-05-04
2025-12-31	$1,369,510	9,656	-0.8%	Shares	Sole	2026-02-09
2025-09-30	$1,366,739	9,736	-1.4%	Shares	Sole	2025-11-04
2025-06-30	$1,241,691	9,879	+2.5%	Shares	Sole	2025-08-07
2025-03-31	$1,066,294	9,641	+1.5%	Shares	Sole	2025-04-22
2024-12-31	$1,297,023	9,502	—	Shares	Sole	2025-02-05
No filing history on record for this holder in this stock.